Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
144-week entecavir treatment in hepatitis B cirrhosis
ChiCTR-ONC-12002094Phase 4Completed
- Sponsor
- 302 Hospital of the People's Liberation Army
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of entecavir in hepatitis B-related liver cirrhosis and Chronic Hepatitis B (CHB), sponsored by 302 Hospital of the People's Liberation Army. Primary endpoints: HBV DNA, FibroScan and 1 more. Started Jan 2012; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B-related liver cirrhosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-ONC-12002094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002094.